UAE Preventive Healthcare market is expected to grow at a CAGR of 12% during 2021-26

According to MarkNtel Advisors’ research report, “UAE Preventive Healthcare Market Analysis, 2021,” the market is likely to grow at a CAGR of 12% during 2021-26 due to easy accessibility to healthcare services, the rising geriatric populace, and the increasing number of patients related to diabetes, respiratory ailment, cardiovascular, and other contagious diseases. Further, hectic schedule and changing lifestyles of people has also increased the occurrence of life associated diseases, thereby propelling the demand for preservative healthcare solutions.

Key questions answered in the study

1. What are the current and future trends in the UAE Preventive Healthcare market? 
2. How has the industry been evolving in terms of geography and services adoption?
3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the UAE Preventive Healthcare market?
5. What is the customer orientation, purchase behavior, and expectations from the UAE Preventive Healthcare market service providers across various regions? 

Cardiovascular Monitors to Grow at a Sturdy Rate                                                     

Amongst various disease monitoring technologies, the market classifies into Cardiovascular Monitors, Blood Pressure Monitors, Obesity Monitors, Asthma Monitors, and Glucose Monitors. Among these segments, Cardiovascular Monitors are likely to grow at a significant rate during the forecast period. The segment growth owes to the rising geriatric population, which is more prone to non-communicable diseases like cardiovascular diseases. Therefore, the demand for cardiovascular monitors increases to lower the risk of cardiovascular diseases, thereby propelling the segment growth. 

“UAE Preventive Healthcare Market Analysis, 2021” provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for Preventive Healthcare providers across the region. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings. 

 Abu Dhabi Exhibits Fastest Growth

Abu Dhabi is likely to register the fastest growth in the UAE Preventive Healthcare market during 2021-26 due to the rapid development of the healthcare industry and increasing demand for healthcare assistance in the region. In addition to this, burgeoning medical tourism fuels market growth. Therefore, based on these factors, Abu Dhabi is likely to contribute to the overall market growth in the forecast period, reveals MarkNtel Advisors in their research report, “UAE Preventive Healthcare Market Analysis, 2021.”

According to MarkNtel Advisors, the major leading players in the UAE Preventive Healthcare Market are McKesson Corporation, Scripto LLC, Omnicell, Inc, Healthways, Inc, Alere, Medtronic, GlaxoSmithKline plc, Pfizer, Inc, Merck & Co, Inc, Omron Healthcare, and Others.

Market Segmentation:

1. By Diseases Monitoring Technologies (Cardiovascular Monitors, Blood Pressure Monitors, Obesity Monitors, Asthma Monitors, Glucose Monitor)
2. By Vaccine (Infectious Diseases Vaccine, Cancer Vaccine, Autism Vaccine, Allergy Vaccine, Other new vaccines (Coronavirus and Polio))
3. By Mode of Prevention (Remote Telemedicine, Medical Devices/Wearable, Home Health Robot, Remote Monitoring, Smart Infusion Pumps)
4. By Region (Dubai, Abu Dhabi, Sharjah & Al Ain)
5. By Competitors (McKesson Corporation, Scripto LLC, Omnicell, Inc, Healthways, Inc, Alere, Medtronic, GlaxoSmithKline plc, Pfizer, Inc, Merck & Co, Inc, Omron Healthcare, Others)